Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:AGE

AgeX Therapeutics (AGE) Stock Price, News & Analysis

AgeX Therapeutics logo

About AgeX Therapeutics Stock (NYSE:AGE)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.22
$16.51
52-Week Range
N/A
Volume
3,700 shs
Average Volume
3,849 shs
Market Capitalization
$11.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AgeX Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

AGE Stock News Headlines

Serina Therapeutics initiated with a Buy at JonesResearch
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
Serina Therapeutics sells UniverXome subsidiary
Serina Therapeutics Inc (SER)
Serina Therapeutics to Present at the 14th Annual Injectables Summit
Russell Skibsted's Net Worth
See More Headlines

AGE Stock Analysis - Frequently Asked Questions

AgeX Therapeutics's stock split before market open on Monday, March 18th 2024.The 8-5 split was announced on Monday, March 18th 2024. The newly minted shares were payable to shareholders after the market closes on Monday, March 18th 2024. An investor that had 100 shares of stock prior to the split would have 160 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that AgeX Therapeutics investors own include Allena Pharmaceuticals (ALNA), Biocept (BIOC), Palatin Technologies (PTN), Aadi Bioscience (AADI), Arbutus Biopharma (ABUS) and Adamis Pharmaceuticals (ADMP).

Company Calendar

Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:AGE
CIK
1708599
Employees
5
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($13.0282)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.80 million
Net Margins
-10,424.65%
Pretax Margin
-10,430.28%
Return on Equity
N/A
Return on Assets
-120.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.13
Quick Ratio
0.36

Sales & Book Value

Annual Sales
$140 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($16.07) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,080,000
Free Float
1,008,000
Market Cap
$11.99 million
Optionable
Not Optionable
Beta
1.18
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NYSE:AGE) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners